Home › Research › Treatments
AI-driven fusion of multimodal data for Alzheimer's disease biomarker assessment
Jasodanand VH, Kowshik SS, Puducheri S, Romano MF, Xu L, Au R, Kolachalama VB.. Nature communications, 2025-08-11
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Alzheimer's disease (AD) diagnosis hinges on detecting amyloid beta (Aβ) plaques and neurofibrillary tau (τ) tangles, typically assessed using PET imaging. While accurate, these modalities are expensive and not widely accessible, limiting their utility in routine clinical practice. Here, we present a multimodal computational framework that integrates data from seven distinct cohorts comprising 12, 185 participants to estimate individual PET profiles using more readily available neurological assessments. Our approach achieved an AUROC of 0.79 and 0.84 in classifying Aβ and τ status, respectively. Predicted PET status was consistent with various biomarker profiles and postmortem pathology, and model-identified regional brain volumes aligned with known spatial patterns of tau deposition. This approach can support scalable pre-screening of candidates for anti-amyloid therapies and clinical trials targeting Aβ and τ, offering a practical alternative to direct PET imaging.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Jasodanand, V. H., Kowshik, S. S., Puducheri, S., Romano, M. F., Xu, L., Au, R., et al. (2025). AI-driven fusion of multimodal data for Alzheimer's disease biomarker assessment. Nature communications. https://doi.org/10.1038/s41467-025-62590-4
Vancouver
Jasodanand VH, Kowshik SS, Puducheri S, Romano MF, Xu L, Au R, et al. AI-driven fusion of multimodal data for Alzheimer's disease biomarker assessment. Nature communications. 2025. doi:10.1038/s41467-025-62590-4. PMID: 40789853.
BibTeX
@article{jasodanand2025-40789853,
author = {Jasodanand, V. H. and Kowshik, S. S. and Puducheri, S. and Romano, M. F. and Xu, L. and Au, R. and Kolachalama, V. B.},
title = {{AI-driven fusion of multimodal data for Alzheimer's disease biomarker assessment}},
journal = {Nature communications},
year = {2025},
doi = {10.1038/s41467-025-62590-4},
pmid = {40789853},
url = {https://doi.org/10.1038/s41467-025-62590-4}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- While accurate, these modalities are expensive and not widely accessible, limiting their utility in routine clinical practice.
- Here, we present a multimodal computational framework that integrates data from seven distinct cohorts comprising 12, 185 participants to estimate individual PET profiles using more readily available neurological assessments.
- Our approach achieved an AUROC of 0.79 and 0.84 in classifying Aβ and τ status, respectively.
- Predicted PET status was consistent with various biomarker profiles and postmortem pathology, and model-identified regional brain volumes aligned with known spatial patterns of tau deposition.
- This approach can support scalable pre-screening of candidates for anti-amyloid therapies and clinical trials targeting Aβ and τ, offering a practical alternative to direct PET imaging.
New to this subject? Start with our plain-English guide: Treatments →
Study details
- Participants185
- Evidence strengthLow
How this study scored 57/100
Published in a leading specialty journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 33 of the 58 points we could judge it on, which is 57 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Nature communications) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 185 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40789853) |
| Free to read | 2 / 2 | Free to read |
| Points | 33 / 58 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 33 of the 58 points we could judge it on is 57 out of 100. |
| Total | 57 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.